Overview
Supplementation of Phosphatidylserine (PS) and n-3 Long Chain Fatty Acids (EPA, DHA) in Children With ADHD
Status:
Completed
Completed
Trial end date:
2005-01-01
2005-01-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
To determine whether supplementation of omega-3 long-chain polyunsaturated fatty acid conjugated to phosphatidylserine rather than triglycerides (fish oil) could affect Attention-deficit/hyperactivity disorder symptoms in children.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Criteria
Inclusion Criteria:- 8 and 13 years of age; diagnosed as having ADHD; otherwise healthy;
Exclusion Criteria:
- significant sensory or neurological limitations, epilepsy, mental retardation,
psychosis, or pervasive developmental disorder; medications with known central nervous
system effects such as tranquilizers, antidepressants, stimulants (including
methylphenidate and amphetamines), sedating antihistamines and some asthma medications
and dietary supplements but vitamins